HEADER APOPTOSIS 09-NOV-08 3F7I TITLE STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ML-IAP RESIDUES 63-172; COMPND 5 SYNONYM: KIDNEY INHIBITOR OF APOPTOSIS PROTEIN, KIAP, MELANOMA COMPND 6 INHIBITOR OF APOPTOSIS PROTEIN, ML-IAP, LIVIN, RING FINGER PROTEIN COMPND 7 50; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BIRC7, KIAP, LIVIN, MLIAP, RNF50, UNQ5800/PRO19607/PRO21344; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS ZINC BINDING, PEPTIDE COMPLEX, APOPTOSIS INHIBITION, PEPTIDOMIMETIC, KEYWDS 2 SMALL MOLECULE, DRUG DESIGN, APOPTOSIS, METAL-BINDING, NUCLEUS, KEYWDS 3 ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR M.C.FRANKLIN,W.J.FAIRBROTHER,F.COHEN REVDAT 5 20-OCT-21 3F7I 1 REMARK SEQADV LINK REVDAT 4 25-OCT-17 3F7I 1 REMARK REVDAT 3 13-JUL-11 3F7I 1 VERSN REVDAT 2 31-MAR-09 3F7I 1 JRNL REVDAT 1 17-MAR-09 3F7I 0 JRNL AUTH F.COHEN,B.ALICKE,L.O.ELLIOTT,J.A.FLYGARE,T.GONCHAROV, JRNL AUTH 2 S.F.KETELTAS,M.C.FRANKLIN,S.FRANKOVITZ,J.P.STEPHAN,V.TSUI, JRNL AUTH 3 D.VUCIC,H.WONG,W.J.FAIRBROTHER JRNL TITL ORALLY BIOAVAILABLE ANTAGONISTS OF INHIBITOR OF APOPTOSIS JRNL TITL 2 PROTEINS BASED ON AN AZABICYCLOOCTANE SCAFFOLD JRNL REF J.MED.CHEM. V. 52 1723 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19228017 JRNL DOI 10.1021/JM801450C REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.ZOBEL,L.WANG,E.VARFOLOMEEV,M.C.FRANKLIN,L.O.ELLIOTT, REMARK 1 AUTH 2 H.J.WALLWEBER,D.C.OKAWA,J.A.FLYGARE,D.VUCIC,W.J.FAIRBROTHER, REMARK 1 AUTH 3 K.DESHAYES REMARK 1 TITL DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF A POTENT SMAC REMARK 1 TITL 2 MIMETIC THAT SENSITIZES CANCER CELLS TO APOPTOSIS BY REMARK 1 TITL 3 ANTAGONIZING IAPS. REMARK 1 REF ACS CHEM. BIOL. V. 1 525 2006 REMARK 1 REFN ISSN 1554-8929 REMARK 1 PMID 17168540 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.VUCIC,M.C.FRANKLIN,H.J.WALLWEBER,K.DAS,B.P.ECKELMAN, REMARK 1 AUTH 2 H.SHIN,L.O.ELLIOTT,K.DESHAYES,G.S.SALVESEN,W.J.FAIRBROTHER REMARK 1 TITL ENGINEERING ML-IAP TO PRODUCE AN EXTRAORDINARILY POTENT REMARK 1 TITL 2 CASPASE-9 INHIBITOR: IMPLICATIONS FOR SMAC-DEPENDENT REMARK 1 TITL 3 ANTI-APOPTOTIC ACTIVITY OF ML-IAP. REMARK 1 REF BIOCHEM. J. V. 385 11 2005 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 15485396 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.C.FRANKLIN,S.KADKHODAYAN,H.ACKERLY,D.ALEXANDRU, REMARK 1 AUTH 2 M.D.DISTEFANO,L.O.ELLIOTT,J.A.FLYGARE,D.VUCIC,K.DESHAYES, REMARK 1 AUTH 3 W.J.FAIRBROTHER REMARK 1 TITL STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF REMARK 1 TITL 2 MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP) REMARK 1 REF BIOCHEMISTRY V. 42 8223 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 21754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1146 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1547 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2020 REMARK 3 BIN FREE R VALUE SET COUNT : 93 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1479 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 198 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 17.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.67000 REMARK 3 B22 (A**2) : -0.67000 REMARK 3 B33 (A**2) : 1.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.104 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.100 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.064 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.278 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1645 ; 0.008 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1148 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2226 ; 1.134 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2743 ; 0.801 ; 3.004 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 181 ; 4.375 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 79 ;34.440 ;23.038 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 220 ;12.425 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;10.202 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 208 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1809 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 382 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 344 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1200 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 788 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 713 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 138 ; 0.133 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 8 ; 0.076 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 33 ; 0.258 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 28 ; 0.156 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1174 ; 1.668 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 370 ; 0.289 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1446 ; 1.922 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 924 ; 1.628 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 780 ; 2.505 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 78 A 167 REMARK 3 RESIDUE RANGE : A 1001 A 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 84.6128 68.0401 22.4991 REMARK 3 T TENSOR REMARK 3 T11: -0.1711 T22: -0.1590 REMARK 3 T33: -0.1665 T12: -0.0033 REMARK 3 T13: 0.0080 T23: 0.0043 REMARK 3 L TENSOR REMARK 3 L11: 2.5097 L22: 3.0086 REMARK 3 L33: 2.0599 L12: -0.5450 REMARK 3 L13: -0.3145 L23: -0.2164 REMARK 3 S TENSOR REMARK 3 S11: 0.0447 S12: 0.1580 S13: -0.0043 REMARK 3 S21: -0.2716 S22: -0.0223 S23: -0.0649 REMARK 3 S31: 0.0037 S32: 0.0191 S33: -0.0225 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 78 B 171 REMARK 3 RESIDUE RANGE : B 1001 B 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 77.9468 59.7263 50.2387 REMARK 3 T TENSOR REMARK 3 T11: -0.1780 T22: -0.1712 REMARK 3 T33: -0.1648 T12: -0.0176 REMARK 3 T13: 0.0137 T23: -0.0004 REMARK 3 L TENSOR REMARK 3 L11: 1.4649 L22: 2.9662 REMARK 3 L33: 1.8183 L12: -0.6503 REMARK 3 L13: 0.5923 L23: -1.0756 REMARK 3 S TENSOR REMARK 3 S11: 0.0092 S12: -0.1074 S13: -0.0137 REMARK 3 S21: 0.1620 S22: -0.0248 S23: -0.0249 REMARK 3 S31: -0.0329 S32: 0.0096 S33: 0.0156 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 1 REMARK 3 ORIGIN FOR THE GROUP (A): 78.2317 62.3793 15.2868 REMARK 3 T TENSOR REMARK 3 T11: 0.0257 T22: -0.0200 REMARK 3 T33: -0.1053 T12: -0.0402 REMARK 3 T13: -0.1077 T23: 0.0273 REMARK 3 L TENSOR REMARK 3 L11: 1.2682 L22: 9.1482 REMARK 3 L33: 22.7654 L12: 3.4039 REMARK 3 L13: -0.8788 L23: -2.8796 REMARK 3 S TENSOR REMARK 3 S11: -0.1345 S12: 1.0789 S13: 0.2447 REMARK 3 S21: -1.1748 S22: 0.2590 S23: 0.8922 REMARK 3 S31: 0.5428 S32: -1.5755 S33: -0.1245 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 1 REMARK 3 ORIGIN FOR THE GROUP (A): 68.4422 54.6548 48.0143 REMARK 3 T TENSOR REMARK 3 T11: -0.1429 T22: -0.1728 REMARK 3 T33: -0.0874 T12: -0.0137 REMARK 3 T13: 0.0102 T23: 0.0371 REMARK 3 L TENSOR REMARK 3 L11: 7.7427 L22: 25.6312 REMARK 3 L33: 3.2847 L12: 3.6851 REMARK 3 L13: 4.0613 L23: -3.3171 REMARK 3 S TENSOR REMARK 3 S11: 0.2302 S12: 0.0407 S13: -0.2862 REMARK 3 S21: -0.2420 S22: -0.4291 S23: 0.4058 REMARK 3 S31: 1.1680 S32: -0.2467 S33: 0.1989 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3F7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050243. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : OSMIC BLUE REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22958 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : 0.11900 REMARK 200 R SYM (I) : 0.11900 REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.64600 REMARK 200 R SYM FOR SHELL (I) : 0.64600 REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: DIFFERENCE FOURIER REMARK 200 STARTING MODEL: 1.3 A STRUCTURE OF THE ML-IAP/XIAP PROTEIN BOUND REMARK 200 TO A DIFFERENT PEPTIDOMIMETIC, WITH THE LIGAND AND SURROUNDING REMARK 200 WATERS REMOVED REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LITHIUM SULFATE, PEG 3350, BIS-TRIS, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.84250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.58150 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.42125 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.58150 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.26375 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.58150 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.42125 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.58150 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.26375 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 36.84250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT EACH ASYMMETRIC UNIT CONTAINS TWO REMARK 300 BIOLOGICAL ASSEMBLIES OF PROTEIN AND LIGAND REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 182 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 40 REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 SER A 43 REMARK 465 HIS A 44 REMARK 465 HIS A 45 REMARK 465 HIS A 46 REMARK 465 HIS A 47 REMARK 465 HIS A 48 REMARK 465 HIS A 49 REMARK 465 SER A 50 REMARK 465 SER A 51 REMARK 465 GLY A 52 REMARK 465 GLU A 53 REMARK 465 VAL A 54 REMARK 465 PRO A 55 REMARK 465 ARG A 56 REMARK 465 GLY A 57 REMARK 465 SER A 58 REMARK 465 HIS A 59 REMARK 465 MET A 60 REMARK 465 LEU A 61 REMARK 465 GLU A 62 REMARK 465 THR A 63 REMARK 465 GLU A 64 REMARK 465 GLU A 65 REMARK 465 GLU A 66 REMARK 465 GLU A 67 REMARK 465 GLU A 68 REMARK 465 GLU A 69 REMARK 465 GLY A 70 REMARK 465 ALA A 71 REMARK 465 GLY A 72 REMARK 465 ALA A 73 REMARK 465 THR A 74 REMARK 465 LEU A 75 REMARK 465 SER A 76 REMARK 465 ARG A 77 REMARK 465 LEU A 168 REMARK 465 THR A 169 REMARK 465 HIS A 170 REMARK 465 SER A 171 REMARK 465 LEU A 172 REMARK 465 MET B 40 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 SER B 43 REMARK 465 HIS B 44 REMARK 465 HIS B 45 REMARK 465 HIS B 46 REMARK 465 HIS B 47 REMARK 465 HIS B 48 REMARK 465 HIS B 49 REMARK 465 SER B 50 REMARK 465 SER B 51 REMARK 465 GLY B 52 REMARK 465 GLU B 53 REMARK 465 VAL B 54 REMARK 465 PRO B 55 REMARK 465 ARG B 56 REMARK 465 GLY B 57 REMARK 465 SER B 58 REMARK 465 HIS B 59 REMARK 465 MET B 60 REMARK 465 LEU B 61 REMARK 465 GLU B 62 REMARK 465 THR B 63 REMARK 465 GLU B 64 REMARK 465 GLU B 65 REMARK 465 GLU B 66 REMARK 465 GLU B 67 REMARK 465 GLU B 68 REMARK 465 GLU B 69 REMARK 465 GLY B 70 REMARK 465 ALA B 71 REMARK 465 GLY B 72 REMARK 465 ALA B 73 REMARK 465 THR B 74 REMARK 465 LEU B 75 REMARK 465 SER B 76 REMARK 465 ARG B 77 REMARK 465 SER B 171 REMARK 465 LEU B 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 25 O HOH A 199 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 197 O HOH B 278 7556 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 119 -134.81 47.65 REMARK 500 GLN B 119 -142.93 49.22 REMARK 500 TYR B 128 -12.13 77.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 124 SG REMARK 620 2 CYS A 127 SG 105.8 REMARK 620 3 HIS A 144 NE2 100.3 117.5 REMARK 620 4 CYS A 151 SG 118.8 108.4 106.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 LI B1002 LI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 93 O REMARK 620 2 ASP B 96 OD1 117.0 REMARK 620 3 HIS B 115 ND1 119.9 101.1 REMARK 620 4 EDO B 174 O2 92.6 108.4 118.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 124 SG REMARK 620 2 CYS B 127 SG 106.9 REMARK 620 3 HIS B 144 NE2 99.4 119.6 REMARK 620 4 CYS B 151 SG 117.6 106.7 107.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G13 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G13 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTB B 173 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 174 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 175 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TW6 RELATED DB: PDB REMARK 900 RELATED ID: 2I3H RELATED DB: PDB REMARK 900 RELATED ID: 2I3I RELATED DB: PDB REMARK 900 RELATED ID: 3F7G RELATED DB: PDB REMARK 900 RELATED ID: 3F7H RELATED DB: PDB DBREF 3F7I A 63 172 UNP Q6R308 Q6R308_HUMAN 63 172 DBREF 3F7I B 63 172 UNP Q6R308 Q6R308_HUMAN 63 172 SEQADV 3F7I MET A 40 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 41 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 42 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 43 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 44 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 45 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 46 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 47 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 48 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 49 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 50 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 51 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 52 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU A 53 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I VAL A 54 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I PRO A 55 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I ARG A 56 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 57 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 58 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 59 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I MET A 60 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I LEU A 61 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU A 62 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 150 UNP Q6R308 SER 150 ENGINEERED MUTATION SEQADV 3F7I GLN A 160 UNP Q6R308 ARG 160 ENGINEERED MUTATION SEQADV 3F7I GLU A 161 UNP Q6R308 ASP 161 ENGINEERED MUTATION SEQADV 3F7I TYR A 162 UNP Q6R308 PHE 162 ENGINEERED MUTATION SEQADV 3F7I ILE A 163 UNP Q6R308 VAL 163 ENGINEERED MUTATION SEQADV 3F7I ASN A 164 UNP Q6R308 HIS 164 ENGINEERED MUTATION SEQADV 3F7I ASN A 165 UNP Q6R308 SER 165 ENGINEERED MUTATION SEQADV 3F7I ILE A 166 UNP Q6R308 VAL 166 ENGINEERED MUTATION SEQADV 3F7I HIS A 167 UNP Q6R308 GLN 167 ENGINEERED MUTATION SEQADV 3F7I LEU A 168 UNP Q6R308 GLU 168 ENGINEERED MUTATION SEQADV 3F7I LEU A 172 UNP Q6R308 GLN 172 ENGINEERED MUTATION SEQADV 3F7I MET B 40 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 41 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 42 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 43 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 44 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 45 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 46 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 47 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 48 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 49 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 50 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 51 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 52 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU B 53 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I VAL B 54 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I PRO B 55 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I ARG B 56 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 57 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 58 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 59 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I MET B 60 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I LEU B 61 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU B 62 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 150 UNP Q6R308 SER 150 ENGINEERED MUTATION SEQADV 3F7I GLN B 160 UNP Q6R308 ARG 160 ENGINEERED MUTATION SEQADV 3F7I GLU B 161 UNP Q6R308 ASP 161 ENGINEERED MUTATION SEQADV 3F7I TYR B 162 UNP Q6R308 PHE 162 ENGINEERED MUTATION SEQADV 3F7I ILE B 163 UNP Q6R308 VAL 163 ENGINEERED MUTATION SEQADV 3F7I ASN B 164 UNP Q6R308 HIS 164 ENGINEERED MUTATION SEQADV 3F7I ASN B 165 UNP Q6R308 SER 165 ENGINEERED MUTATION SEQADV 3F7I ILE B 166 UNP Q6R308 VAL 166 ENGINEERED MUTATION SEQADV 3F7I HIS B 167 UNP Q6R308 GLN 167 ENGINEERED MUTATION SEQADV 3F7I LEU B 168 UNP Q6R308 GLU 168 ENGINEERED MUTATION SEQADV 3F7I LEU B 172 UNP Q6R308 GLN 172 ENGINEERED MUTATION SEQRES 1 A 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 A 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 A 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 A 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 A 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 A 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 A 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 A 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 A 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 A 133 HIS SER LEU SEQRES 1 B 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 B 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 B 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 B 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 B 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 B 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 B 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 B 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 B 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 B 133 HIS SER LEU HET ZN A1001 1 HET G13 A 1 35 HET ZN B1001 1 HET LI B1002 1 HET G13 B 1 35 HET BTB B 173 14 HET EDO B 174 4 HET EDO B 175 4 HETNAM ZN ZINC ION HETNAM G13 N-[(3AR,6S,6AS)-1-(N-METHYL-L-ALANYL-3-METHYL-L-VALYL) HETNAM 2 G13 OCTAHYDROCYCLOPENTA[B]PYRROL-6-YL]NAPHTHALENE-1- HETNAM 3 G13 CARBOXAMIDE HETNAM LI LITHIUM ION HETNAM BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL- HETNAM 2 BTB PROPANE-1,3-DIOL HETNAM EDO 1,2-ETHANEDIOL HETSYN BTB BIS-TRIS BUFFER HETSYN EDO ETHYLENE GLYCOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 G13 2(C28 H38 N4 O3) FORMUL 6 LI LI 1+ FORMUL 8 BTB C8 H19 N O5 FORMUL 9 EDO 2(C2 H6 O2) FORMUL 11 HOH *198(H2 O) HELIX 1 1 PHE A 81 GLY A 85 5 5 HELIX 2 2 SER A 86 SER A 93 1 8 HELIX 3 3 PRO A 104 ALA A 111 1 8 HELIX 4 4 ASP A 139 PHE A 148 1 10 HELIX 5 5 CYS A 151 GLY A 159 1 9 HELIX 6 6 GLY A 159 HIS A 167 1 9 HELIX 7 7 PHE B 81 GLY B 85 5 5 HELIX 8 8 SER B 86 SER B 93 1 8 HELIX 9 9 PHE B 94 TRP B 97 5 4 HELIX 10 10 PRO B 104 ALA B 111 1 8 HELIX 11 11 ASP B 139 PHE B 148 1 10 HELIX 12 12 CYS B 151 GLY B 159 1 9 HELIX 13 13 GLY B 159 HIS B 170 1 12 SHEET 1 A 3 PHE A 113 HIS A 115 0 SHEET 2 A 3 VAL A 122 CYS A 124 -1 O ARG A 123 N PHE A 114 SHEET 3 A 3 GLY A 130 LEU A 131 -1 O LEU A 131 N VAL A 122 SHEET 1 B 3 PHE B 113 HIS B 115 0 SHEET 2 B 3 VAL B 122 CYS B 124 -1 O ARG B 123 N PHE B 114 SHEET 3 B 3 GLY B 130 LEU B 131 -1 O LEU B 131 N VAL B 122 LINK SG CYS A 124 ZN ZN A1001 1555 1555 2.33 LINK SG CYS A 127 ZN ZN A1001 1555 1555 2.34 LINK NE2 HIS A 144 ZN ZN A1001 1555 1555 2.08 LINK SG CYS A 151 ZN ZN A1001 1555 1555 2.31 LINK O SER B 93 LI LI B1002 1555 1555 1.84 LINK OD1 ASP B 96 LI LI B1002 1555 1555 1.81 LINK ND1 HIS B 115 LI LI B1002 1555 1555 1.93 LINK SG CYS B 124 ZN ZN B1001 1555 1555 2.33 LINK SG CYS B 127 ZN ZN B1001 1555 1555 2.31 LINK NE2 HIS B 144 ZN ZN B1001 1555 1555 2.10 LINK SG CYS B 151 ZN ZN B1001 1555 1555 2.31 LINK O2 EDO B 174 LI LI B1002 1555 1555 1.81 SITE 1 AC1 4 CYS A 124 CYS A 127 HIS A 144 CYS A 151 SITE 1 AC2 10 LYS A 121 GLY A 130 LEU A 131 GLN A 132 SITE 2 AC2 10 SER A 133 TRP A 134 ASP A 138 GLU A 143 SITE 3 AC2 10 TRP A 147 HOH A 289 SITE 1 AC3 4 CYS B 124 CYS B 127 HIS B 144 CYS B 151 SITE 1 AC4 4 SER B 93 ASP B 96 HIS B 115 EDO B 174 SITE 1 AC5 13 GLU A 106 LYS B 121 GLY B 130 LEU B 131 SITE 2 AC5 13 GLN B 132 SER B 133 ASP B 138 GLU B 143 SITE 3 AC5 13 TRP B 147 HOH B 196 HOH B 274 HOH B 276 SITE 4 AC5 13 HOH B 283 SITE 1 AC6 8 PRO B 82 GLY B 83 SER B 86 LYS B 146 SITE 2 AC6 8 TRP B 147 HIS B 167 HIS B 170 HOH B 268 SITE 1 AC7 8 SER A 93 HOH A 232 SER B 93 ASP B 96 SITE 2 AC7 8 HIS B 115 GLY B 117 HOH B 258 LI B1002 SITE 1 AC8 5 CYS B 127 PHE B 148 PRO B 149 GLY B 150 SITE 2 AC8 5 HOH B 183 CRYST1 87.163 87.163 73.685 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011473 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013571 0.00000 MASTER 582 0 8 13 6 0 16 6 0 0 0 22 END